EC orders repolling at five booths in Haryana on Oct 23

Date:

The Election Commission has scheduled repolling at five polling stations in Haryana on Wednesday, October 23, after some shortcomings were noticed. It will be held from 7 am to 6 pm.

Re-polling will be held in booth numbers 71 of Uchana Kalan assembly constituency in Jind district, 161 of Beri constituency in Jhajjar district, 28 of Narnaul assembly constituency in Narnaul district, 18 of Kosli in district Rewari and booth number 113 of Prithla in Faridabad district, state’s joint chief electoral officer Dr Inder Jeet said on Tuesday.

ALSO READ: Rapid Metro, Gurugram to be operated by Delhi Metro from tonight

“In the polls which were held in Haryana on Monday, some shortcomings were noticed in five booths after which the Election Commission ordered re-polling in these booths,” he said.

The poll watchdog has also revised turnout for the Haryana Assembly elections on October 21 to 68.31%. Polling to 90 Assembly seats was held in Haryana on Monday. Results will be declared on Thursday.

(With agency inputs)

Click here for Latest News updates and viral videos on our AI-powered smart news

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

IPL 2024: SRH Qualifies For Playoffs As Match Against Gujarat Abandoned Due To Rain

Sunrisers Hyderabad have officially became the third team to qualify for playoffs

Three Year Old Dead After Parent’s Forget Her In Car, Attend Wedding

As per the police, the incident occurred on Wednesday evening and the girl has been identified as Gorvika Nagar

IPL 2024: Toss Delayed In Sunrisers Hyderabad-Gujarat Titans Clash Due To Rain

It will be a crucial match for the Hyderabad-based franchise since they have to win the match to qualify for the playoffs of the IPL 2024

Another Rare Blood Disorder Linked To AstraZeneca Covid Vaccine Found

Researchers have found that the AstraZeneca vaccine sold in India under the brand name Covishield is linked to a rare blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)